Sentence examples for imputed efficacy from inspiring English sources

The imputed efficacy estimates were then used in the dynamic impact model.

The imputed efficacy calculations suggest that tenofovir gel reduced the per sex-act probability of HIV acquisition by 54%95%5% CrI 8-83%) and the per sex-act probability of HSV-2 acquisition by 71%95%5% CrI 30-97%).

However, the wide bounds on the imputed efficacy estimates of tenofovir gel, due to the wide confidence intervals on the trial effectiveness estimates, lead to a wide range of population-level impact estimates predicted by the model.

*Assuming 30% uptake after 10 years and trial consistency of gel use and mean imputed efficacy estimates, 10% product wastage during distribution, and a 3% discount rate on costs and effects.

We are also reassured about the validity of our imputed efficacy estimates because a secondary analyses of the effectiveness among 'high adherers' in the trial (i.e. women who used both doses of the gel in over 80% of sex-acts) found that the risk of HIV acquisition in this population was reduced by 54% (95%CI 4-80%) [ 5].

The last observation carried forward (LOCF) approach was used to impute missing efficacy data.

Significant differences were noted in the ability to impute from the OmniExpress and Affymetrix 6.0, and imputation efficacy using MACH was much lower in general than previously reported [16].

Imputed SNPs with R less than 0.3 were considered to be of poor quality and were excluded from analysis of imputation efficacy and genotyping concordance.

The concordance rates between the imputed and observed genotypes were used as a measure of imputation accuracy and the proportion of non-missing genotypes as a measure of imputation efficacy.

We report the concordance rate between the imputed and observed genotypes for the masked SNPs as a measure of imputation accuracy and the proportion of non-missing genotypes under a given INFO score threshold as a measure of the imputation efficacy.

Observed data are presented alongside imputed data for all efficacy variables in the CZP completer, CZP ITT and dose-reduction populations.